Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society-Reference-Cited by-同舟云学术

Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society

Published:2019-06 Issue: Volume:31 Page:173-188
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Lebrun Christine,Vukusic Sandra

Funder

Hospices Civils de Lyon

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference65 articles.

1. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations;Ahlgren;Acta Neurol. Scand.,2009

2. Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial program;Angelo;Pharmacoepidemiol. Drug Saf.,2014

3. Hepatitis B vaccination and the risk of multiple sclerosis;Ascherio;N. Engl. J. Med,2001

4. Audition publique ‘Vaccination contre le virus de l'hépatite B et sclérose en plaques: état des lieux’. Rapport d'orientation de la commission d'audition du 24 novembre 2004). https://www.has-sante.fr/portail/upload/docs/application/pdf/VHB_audition%20publique.PDF, (accessed 28.12.2018).

5. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden;Bardage;BMJ,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorizations to January 2024;Expert Review of Vaccines;2024-09-11

2. Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study;Vaccine;2024-09

3. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society;Multiple Sclerosis Journal;2024-02-15

4. Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis;Journal of the Neurological Sciences;2024-01

5. Cancer et sclérose en plaques : recommandations 2023 de la Société française de la sclérose en plaques;Pratique Neurologique - FMC;2023-12